BTB Therapeutics, Inc.
PrivateLast Round
Seed Round
Aug 12, 2026
Est. Valuation
$6.42M
Total Funding Raised
$11.96M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BTB Therapeutics, Inc. is a drug discovery company developing non-opioid analgesics and RNA-modifying compounds to treat rare genetic diseases and enhance cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BTB Therapeutics, Inc. Comparables
Compare BTB Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neumentum, Inc. | 86% | |
| Allay Therapeutics | 84% | |
| Concentric Analgesics | 83% | |
BTB Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 12, 2026 | ||||
| Early Funding | Nov 1, 2025 | ||||
| Seed | Feb 5, 2025 | ||||
| Convertible Debt | Jun 24, 2024 | ||||
| Convertible Debt | Oct 27, 2023 | ||||
VC Round | Apr 4, 2023 |
Key People
Founding team and executive leadership
BTB Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kyoto University Innovation Capital | Early Funding, Convertible Debt, Seed |
| SMBC Venture Capital | Early Funding, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2026
Raised $9M in Seed funding.
- Nov 1, 2025
$7M raised in early funding.
BTB Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BTB Therapeutics, Inc.'s valuation, stock price, and market status.